United States
Australia
Brazil
Canada
Germany
Ireland
Japan
Mexico
New Zealand
Philippines
South Africa
United Kingdom
Gastrointestinal Cancer Update
From Dr. Neil Love
Science
Prostate Cancer Update
by Dr. Neil Love
Today: #185 in Science, India on our combined chart.
Chart positions today · India
Not on the United States charts we track today.
Not on the United Kingdom charts we track today.
Not on the Canada charts we track today.
Not on the Australia charts we track today.
Not on the Germany charts we track today.
Not on the Brazil charts we track today.
Not on the Mexico charts we track today.
Not on the New Zealand charts we track today.
Not on the Ireland charts we track today.
Not on the Japan charts we track today.
Not on the Philippines charts we track today.
Not on the South Africa charts we track today.
If you like Prostate Cancer Update, try…
Gynecologic Oncology Update
From Dr. Neil Love
Breast Cancer Insights
Similar topics: asco and cancer
ASCO Daily News
Similar topics: asco and cancers
On Target
Similar topics: prostate and cancer
CME in Minutes: Education in Oncology & Hematology
Similar topics: cancer and prostate
Ranking history · India
Latest daily rankings: Oct 22. New rankings will appear after the next update.
Position on the Science, India combined chart over the last 7 days. Toggle platforms to compare their positions. Lower rank numbers are better.
View as table
| Date | Combined Rank | Apple Podcasts | Castbox |
|---|---|---|---|
| Oct 22 | #185 | #185 | — |
| Oct 21 | #162 | #163 | — |
| Oct 20 | #128 | #129 | — |
| Oct 19 | #78 | #78 | #77 |
Latest episodes
-
Prostate Cancer with PTEN Deficiency — An Interview with Dr Neeraj Agarwal
October 3, 2026 · 52 minFeaturing an interview with Dr Neeraj Agarwal, including the following topics: Impact of PTEN deficiency on PI3K/AKT/mTOR pathway; optimal approaches to testing (0:00)Approaches to monitoring for disease progression in patients who are…
-
Metastatic Bladder Cancer — Rapid Case Review Issue 8
September 16, 2026 · 26 minFeaturing perspectives from Dr Alexandra Drakaki, including the following topics: Case: A man in his late 70s with diabetes and metastatic bladder cancer achieves radiographic response with enfortumab vedotin (EV) and pembrolizumab but…
-
Metastatic Bladder Cancer — Rapid Case Review Issue 7
September 16, 2026 · 36 minFeaturing perspectives from Dr Alexandra Drakaki, including the following topics: Case: A man in his early 80s with bladder cancer and metastatic progression in the viscera and lymph nodes receives enfortumab vedotin (EV) with…
-
Prostate Cancer — The Optimal Use of Hormonal Therapy
September 8, 2026 · 59 minFeaturing perspectives from Dr William K Oh and Dr Mary-Ellen Taplin, including the following topics: Introduction: Another Perspective on the Treatment of Localized Prostate Cancer (0:00)Nonmetastatic Disease (10:32)Metastatic Androgen…
-
AKT Inhibition in Prostate Cancer — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium
September 5, 2026 · 18 minFeaturing perspectives from Dr Karim Fizazi, Dr Daniel George and Dr Elisabeth I Heath, moderated by Dr Heath, including the following topics: Tolerability of capivasertib and management of associated side effects — Question from Neeraj…
Show 7 more episodesShow fewer episodes
-
For Oncology Nurses: Prostate Cancer — Proceedings from the 2026 Annual ONS Congress
August 31, 2026 · 1 hr 28 minFeaturing perspectives from Mr Michael Lai, Dr Scott T Tagawa, Ms Stacy E Walker and Dr Evan Y Yu, moderated by Dr Tagawa, including the following topics: Introduction (0:00)Overview of Prostate Cancer (3:00)Hormonal Therapy for…
-
Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Microlearning Activity 4: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium
August 27, 2026 · 15 minFeaturing perspectives from Dr Terence Friedlander, Dr Matthew Galsky, Dr Shilpa Gupta and Prof Andrea Necchi, moderated by Dr Friedlander, including the following topics: Case: A patient with T4 disease, pelvic wall involvement and a…
-
Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium
August 26, 2026 · 20 minFeaturing perspectives from Dr Terence Friedlander, Dr Matthew Galsky, Dr Shilpa Gupta and Prof Andrea Necchi, moderated by Dr Friedlander, including the following topics: Case: A man in his early 80s with non-muscle-invasive bladder…
-
AKT Inhibition in Prostate Cancer — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium
August 22, 2026 · 19 minFeaturing perspectives from Dr Karim Fizazi, Dr Daniel George and Dr Elisabeth I Heath, moderated by Dr Heath, including the following topics: Treatment approach for AKT-mutated prostate cancer — Question from Neeraj Agarwal, MD, FASCO…
-
AKT Inhibition in Prostate Cancer — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium
August 21, 2026 · 17 minFeaturing perspectives from Dr Karim Fizazi, Dr Daniel George and Dr Elisabeth I Heath, moderated by Dr Heath, including the following topics: Role of PTEN deficiency in tumorigenesis of prostate cancer and optimal approach to PTEN…
-
Genitourinary Cancers — Reviewing Key Presentations from the 2026 ASCO Annual Meeting
August 19, 2026 · 1 hr 30 minFeaturing perspectives from Dr Rahul Aggarwal, Dr Matthew D Galsky and Dr Tian Zhang, including the following topics: Introduction: Welcome GU Oncology Fellows! (0:00)Prostate Cancer — Dr Aggarwal (12:48)Urothelial Bladder Cancer — Dr…
-
Metastatic Bladder Cancer — Rapid Case Review Issue 6
August 18, 2026 · 26 minFeaturing perspectives from Prof Yohann Loriot, including the following topics: Case: A man in his early 80s with metastatic urothelial bladder cancer (mUBC) receives enfortumab vedotin (EV)/pembrolizumab but experiences immune-related…
About the show
Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing urologists and radiation oncologists ongoing access to the perspectives and opinions of national and international prostate cancer research leaders.